PAF. A review of its effects, antagonists and possible future clinical implications (Part II)
about
Sperm preparation for ARTCharacterization of the de novo biosynthetic enzyme of platelet activating factor, DDT-insensitive cholinephosphotransferase, of human mesangial cellsThe third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins. Studies using intracellular domain minigenes and receptor chimerasGlycerophospholipid Biosynthetic PathwayStructurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor.Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limbSignal transduction mechanisms and behavioral sensitization to stimulant drugs: an overview of cAMP and PLA2.Experimental and emerging therapies for sepsis and septic shock.Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis.Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsyInteraction between PAF and human platelet membranes: a fluorescence study.Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.Isolation and structural elucidation of biologically active phospholipids from Scytonema julianum (cyanobacteria).Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations.Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.Inflammation, not Cholesterol, Is a Cause of Chronic Disease.
P2860
Q24799231-25B249A7-624A-40C6-BAAC-5350010457B9Q28219806-9202E43D-B25A-4B75-946B-1142C27E77A7Q28574392-B14A5B48-202E-4FB2-AA37-5082BCFA17E5Q30230798-9AD00756-B241-4629-AEF2-2A2E7E552EDFQ34002901-16F2E823-C0BC-4004-BDF0-FBAE7EF3F5A6Q34184802-84404879-33D5-415C-A660-D8DFD4F5AAD9Q34420274-710126C9-A80F-4612-8812-9746EA11081AQ34481636-37F234AF-62B3-4DE6-9706-807CDE04CBBCQ35897129-63C21120-0890-4F96-B521-6163208CBE88Q37238455-0CF84636-F160-4CE8-BA68-4989A44E3A20Q41954982-ED25CC2D-87FF-4F04-B5A9-FAAC383B1DD7Q42198666-16F16C2E-3F14-4F5D-87C0-69A94652E860Q42371085-83E80432-1BE7-4680-B01B-A07FD22DB006Q42704555-CC6F4B8E-C9BE-4999-A0CF-6E90C24E136FQ43002193-DAB9D6CD-BD56-4113-9639-A8237F9DCA4DQ44390798-867BBE84-75DF-40A7-B8C6-9097731E82A9Q48925745-E96744EF-264F-4C4C-86C5-87D431029A91Q55446683-555E331E-D41F-4E00-8B1E-5DDD3B6885D4
P2860
PAF. A review of its effects, antagonists and possible future clinical implications (Part II)
description
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1991
@ast
im August 1991 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1991/08/01)
@sk
vědecký článek publikovaný v roce 1991
@cs
wetenschappelijk artikel (gepubliceerd op 1991/08/01)
@nl
наукова стаття, опублікована в серпні 1991
@uk
مقالة علمية (نشرت في أغسطس 1991)
@ar
name
PAF. A review of its effects, ...... linical implications (Part II)
@ast
PAF. A review of its effects, ...... linical implications (Part II)
@en
PAF. A review of its effects, ...... linical implications (Part II)
@nl
type
label
PAF. A review of its effects, ...... linical implications (Part II)
@ast
PAF. A review of its effects, ...... linical implications (Part II)
@en
PAF. A review of its effects, ...... linical implications (Part II)
@nl
prefLabel
PAF. A review of its effects, ...... linical implications (Part II)
@ast
PAF. A review of its effects, ...... linical implications (Part II)
@en
PAF. A review of its effects, ...... linical implications (Part II)
@nl
P2093
P1433
P1476
PAF. A review of its effects, ...... linical implications (Part II)
@en
P2093
P304
P356
10.2165/00003495-199142020-00002
P577
1991-08-01T00:00:00Z
P6179
1018815321